131st MAINE LEGISLATURE
LD 223 LR 603(01)
Resolve, Directing the Department of Health and Human Services to Amend Its Rules Regarding Pharmacy Services
Preliminary Fiscal Impact Statement for Original Bill
Sponsor: Rep. Zager of Portland
Committee: Health and Human Services
Fiscal Note Required: Yes
             
Preliminary Fiscal Impact Statement
FY 2023-24 FY 2024-25 Projections  FY 2025-26 Projections  FY 2026-27
Net Cost (Savings)
General Fund $149,184 $216,062 $216,062 $216,062
Appropriations/Allocations
General Fund $149,184 $216,062 $216,062 $216,062
Federal Expenditures Fund $291,329 $332,712 $332,712 $332,712
Other Special Revenue Funds $2,908 $5,816 $5,816 $5,816
Federal Block Grant Fund $5,321 $13,672 $13,672 $13,672
Revenue
Federal Expenditures Fund $291,329 $332,712 $332,712 $332,712
Other Special Revenue Funds $2,908 $5,816 $5,816 $5,816
Federal Block Grant Fund $5,321 $13,672 $13,672 $13,672
Fiscal Detail and Notes
The Department of Health and Human Services will require General Fund appropriations of $149,184 in fiscal year 2023-24 and $216,062 in fiscal year 2024-25 to allow a pharmacist licensed under the Maine Revised Statutes, Title 32, chapter 117 to be reimbursed for providing medication evaluation or consultation to a MaineCare member via telehealth or in a home visit when technology is not the most effective mode of consultation for services. Federal Expenditures Fund and Federal Block Grant Fund allocations will also be required for the FMAP match and Other Special Revenue Funds allocations for the Service Provider Tax.